Pure Global AI
NCT06364722Completed

Effect of Acupuncture on the Microbiota-gut-brain Axis in Crohn's Disease

Shanghai Institute of Acupuncture, Moxibustion and MeridianClinicalTrials.govother
Verified
Study focus
Disease/Condition
Crohn Disease
Drug/Device/Intervention
Acupuncture treatment
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Timeline & enrollment
Phase
N/A
Start date
May 01, 2015
End date
Mar 28, 2024
Enrollment
64 participants
Primary outcome

Effect of Acupuncture on Crohn's Disease Activity Index (CDAI)

Summary

Multidisciplinary techniques such as multimodal neuroimaging, microbiology, and
 bioinformatics were applied to study the differences in correlation characteristics between
 gut microbes, functional brain networks, and peripheral inflammation among patients with
 active Crohn's disease (CD), CD in remission, and healthy subjects.

ICD-10 classifications
Crohn disease, unspecifiedOther Crohn diseaseCrohn disease of large intestineCrohn disease of small intestineCrohn disease [regional enteritis]
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06364722
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06364722 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Institute of Acupuncture, Moxibustion and Meridian and is currently Completed. The study focuses on Crohn Disease. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.